未登录

P

Prabhash Nath Tripathi

Department of Pharmaceutical Technology

H指数:20

被引数:1,692

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction to: Ameliorative Role of Phosphodiesterase-5 (PDE-5) Inhibitor “Avanafil” Via Modulating cAMP & cGMP Pathway Against Alzheimer’s Disease

更正：通过调节cAMP & cGMP通路，磷脂酶-5（PDE-5）抑制剂“Avanafil”对阿尔茨海默病的改善作用

Neurochemical Research

IF3.8

2025-09-060

PRE

Ameliorative Role of Phosphodiesterase-5 (PDE-5) Inhibitor “Avanafil” via Modulating cAMP & cGMP Pathway Against Alzheimer’s Disease

磷odiesterase-5（PDE-5）抑制剂“Avanafil”通过调节cAMP与cGMP通路改善阿尔茨海默病的作用

Neurochemical Research

IF3.8

2025-08-130

PRE

Emerging Trends: Neurofilament Biomarkers in Precision Neurology

NEUROCHEMICAL RESEARCH

IF3.8

2024-09-302

PRE

Multifaceted Neuroprotective Role of Punicalagin: A Review

NEUROCHEMICAL RESEARCH

IF3.8

2023-12-128

PRE

Drug reposition-based design, synthesis, and biological evaluation of dual inhibitors of acetylcholinesterase and ,B-Secretase for treatment of Alzheimer?s disease

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2022-08-0112

PRE

Design, synthesis, and evaluation of some novel biphenyl imidazole derivatives for the treatment of Alzheimer's disease

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2021-12-0118

PREAI

Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer's Disease (vol 10, pg 4361, 2019)

ACS CHEMICAL NEUROSCIENCE

IF3.9

2020-08-033

PREAI

Computational exploration and experimental validation to identify a dual inhibitor of cholinesterase and amyloid-beta for the treatment of Alzheimer's disease

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

IF3.1

2020-06-0318

PREAI

Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-12-0161

PREAI

Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer's Disease

ACS CHEMICAL NEUROSCIENCE

IF3.9

2019-09-0652

PREAI

Design, synthesis, and evaluation of novel N-(4-phenoxybenzyl) aniline derivatives targeting acetylcholinesterase, β-amyloid aggregation and oxidative stress to treat Alzheimer's disease

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2019-08-0117

PREAI

Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-04-0186

PREAI

Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2019-04-0136

OAAI

Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies

PROGRESS IN NEUROBIOLOGY

IF6.1

2019-03-01258

PREAI

Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-02-01143

PREAI

Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2017-08-0156

PREAI

Design, synthesis and evaluation of some N-methylenebenzenamine derivatives as selective acetylcholinesterase (AChE) inhibitor and antioxidant to enhance learning and memory

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2017-02-0127

PREAI

Effect of Semicarpus anacardium on the cell cycle of DU-145 cells

半孢子虫对DU-145细胞周期的影响

IF8.3

1998-10-016

PREAI